Literature DB >> 874104

Massive extranglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy.

D L Hemsell, C D Edman, J F Marks, P K Siiteri, P C MacDonald.   

Abstract

This report describes the mechanism of origin and the quantity of estrogen produced in a prepubertal boy who developed severe feminization at 8 yr of age as the result of a heretofore undescribed metabolic abnormality. The clinical findings were gynecomastia and accelerated linear growth and bone maturation. At the time feminization developed, there were no signs of growth or development of the otherwise normal prepubertal male external genitalia or any increase of muscle mass that normally accompanies male puberty. The hyperestrogenism was found to be the consequence of massive extraglandular conversion of plasma androstenedione to estrone. During a 6-mo period of study, the plasma production rate of androstenedione ranged from 1.2 to 1.6 mg/day. More than 55% of plasma androstenedione was metabolized by aromatization to estrone which, in turn, was extensively sulfurylated in the tissue sites of aromatization before its entry into the blood. Thus, estrone sulfate was the final product in the aromatizing sites, and the plasma production rate of estrone sulfate derived from plasma androstenedione was 782 mug/24 h. The extent of extraglandular conversion of plasma androstenedione to estrone measured in this boy was 50 times that observed in two normal prepubertal boys. Moreover, 94% of the extraglandular aromatization occurred in extrahepatic sites. The metabolic clearance rate of plasma androstenedione, 2,380 liters/day per m(2), was markedly increased in this boy. Approximately 1,500 liters of plasma androstenedione clearance was accounted for by extrahepatic, extraglandular aromatization. The fractional conversion of testosterone to estradiol, 0.16, was 50 times greater in this boy than that observed in normal young adult men. The total extent of aromatization of plasma prehormones was even greater in this boy inasmuch as evidence was obtained that aromatization of 16-hydroxysteroids, e.g. 16alpha-hydroxy androstenedione and 16alpha-hydroxy dehydroisoandrosterone (sulfate), resulted in estriol formation independent of estrone formation. Thus, extensive extrahepatic, extraglandular aromatization resulted in advanced feminization in this prepubertal boy by a previously undescribed metabolic abnormality.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874104      PMCID: PMC372388          DOI: 10.1172/JCI108796

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; day-to-day and diurnal variations.

Authors:  C J MIGEON; A R KELLER; B LAWRENCE; T H SHEPARD
Journal:  J Clin Endocrinol Metab       Date:  1957-09       Impact factor: 5.958

2.  The oxidation of steroids with tert.-butyl chromate.

Authors:  E Menini; J K Norymberski
Journal:  Biochem J       Date:  1962-07       Impact factor: 3.857

3.  Hepatic circulation in cirrhosis of the liver.

Authors:  S E BRADLEY; F J INGELFINGER; G P BRADLEY
Journal:  Circulation       Date:  1952-03       Impact factor: 29.690

4.  Hormonal changes in puberty. 3. Correlation of plasma testosterone, LH, FSH, testicular size, and bone age with male pubertal development.

Authors:  G P August; M M Grumbach; S L Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

5.  Fetal liver as an endocrine tissue.

Authors:  W R Slaunwhite; M A Karsay; A Hollmer; A A Sandberg; K Niswander
Journal:  Steroids       Date:  1965       Impact factor: 2.668

6.  Plasma 17-ketosteroids and testosterone in prepubertal children before and after ACTH administration.

Authors:  R L Rosenfield; B J Grossman; N Ozoa
Journal:  J Clin Endocrinol Metab       Date:  1971-08       Impact factor: 5.958

7.  The development of steroidogenesis.

Authors:  D B Villee
Journal:  Am J Med       Date:  1972-11       Impact factor: 4.965

8.  Measurement of testosterone and 17-ketosteroids in plasma by the double isotope dilution derivative technique.

Authors:  H M Gandy; R E Peterson
Journal:  J Clin Endocrinol Metab       Date:  1968-07       Impact factor: 5.958

9.  Secretion of unconjugated androgens and estrogens by the normal and abnormal human testis before and after human chorionic gonadotropin.

Authors:  R L Weinstein; R P Kelch; M R Jenner; S L Kaplan; M M Grumbach
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  Androstenedione and its conversion to plasma testosterone in congenital adrenal hyperplasia.

Authors:  R Horton; S D Frasier
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

View more
  11 in total

1.  The Development and Initial Validation of PUMC Localized Scleroderma Facial Aesthetic Index: A Pilot Study.

Authors:  Hayson Chenyu Wang; Shiqi Ling; Xiaojun Wang; Xiao Long; Elliot Tianyu Sun; Nanze Yu; Ruijia Dong; Ang Zeng; Hailin Zhang; Chang Shu
Journal:  Aesthetic Plast Surg       Date:  2021-01-15       Impact factor: 2.326

2.  An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors.

Authors:  Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2013-12       Impact factor: 5.958

3.  pathogenesis of the henny feathering trait in the Sebright bantam chicken. Increased conversion of androgen to estrogen in skin.

Authors:  F W George; J D Wilson
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

4.  Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids.

Authors:  G D Berkovitz; A Guerami; T R Brown; P C MacDonald; C J Migeon
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

5.  Estrogen biosynthesis in human H295 adrenocortical carcinoma cells.

Authors:  Moira R Nicol; Georgia Papacleovoulou; Dean B Evans; Trevor M Penning; Mark W J Strachan; Andrew Advani; Sarah J Johnson; Richard Quinton; J Ian Mason
Journal:  Mol Cell Endocrinol       Date:  2008-11-05       Impact factor: 4.102

6.  Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.

Authors:  D B Lubahn; J S Moyer; T S Golding; J F Couse; K S Korach; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

7.  Influence of cell culture conditions on aromatase activity in human genital skin fibroblasts.

Authors:  T Bisat; T R Brown; C J Migeon; G D Berkovitz
Journal:  In Vitro Cell Dev Biol       Date:  1989-09

Review 8.  Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis.

Authors:  Makio Shozu; Maki Fukami; Tsutomu Ogata
Journal:  Expert Rev Endocrinol Metab       Date:  2014-07

9.  A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue.

Authors:  Hong Zhao; Joy Innes; David C Brooks; Scott Reierstad; Mehmet B Yilmaz; Zhihong Lin; Serdar E Bulun
Journal:  Reprod Biol Endocrinol       Date:  2009-04-24       Impact factor: 5.211

10.  Aromatase excess syndrome presenting with prepubertal gynecomastia in an Egyptian child with type 1 neurofibromatosis.

Authors:  Kotb Abbass Metwalley; Hekma Saad Farghaly
Journal:  Indian J Hum Genet       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.